Copyright
©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 99745
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.99745
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.99745
Table 1 Compound list
| Compound | CAS |
| Deoxyshikonin | 43043-74-9 |
| Shikonin | 517-89-5 |
| Lithospermoside | 63492-69-3 |
| β,β-Dimethylacrylshikonin | 24502-79-2 |
| β,β-Dimethylacrylalkannin | 34539-65-6 |
| Lithospermic acid | 28831-65-4 |
| β-Acetoxyisovalerylshikonin | 69091-17-4 |
| Isobutylshikonin | 52438-12-7 |
| Acetylshikonin | 24502-78-1 |
| Isobavachalcone | 20784-50-3 |
| Bavachin | 19879-32-4 |
| Isobavachin | 31524-62-6 |
| Bavachinin | 19879-30-2 |
| 4'-O-Methylbavachalcone | 20784-60-5 |
| Psoralen | 66-97-7 |
| Corylin | 53947-92-5 |
| Psoralidin | 18642-23-4 |
| Astragalin | 480-10-4 |
| Methoxsalen | 298-81-7 |
| Bakuchiol | 10309-37-2 |
| Angelicin | 523-50-2 |
| Neobavaisoflavone | 41060-15-5 |
| Cinnamaldehyde | 104-55-2 |
| Cinnamic acid | 621-82-9 |
| Cinnamon alcohol | 104-54-1 |
| Cinnamyl acetate | 103-54-8 |
| Trans-cinnamic acid | 140-10-3 |
| p-Hydroxy-cinnamic acid | 7400-08-0 |
| 2-Methoxycinnamic acid | 6099-03-2 |
| Methyl 4-hydroxycinnamate | 3943-97-3 |
| 3,4,5-Trimethoxycinnamic acid | 90-50-6 |
Table 2 The minimum inhibitory concentrations of gromwell root compounds (μg/mL)
| Compound | Klebsiella pneumoniae | Pseudomonas aeruginosa | Acinetobacter baumannii | Staphylococcus aureus | Candida albicans | Cryptococcus neoformans | Helicobacter pylori |
| Shiconin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 2 |
| Lithospermoside | > 128 | > 128 | > 128 | > 128 | 8 | 4 | > 128 |
| β,β-Dimethylacrylshikonin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 32 |
| β,β-Dimethylacrylalkannin | > 128 | > 128 | > 128 | > 128 | 32 | 8 | 32 |
| Lithospermic acid | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| β-Acetoxyisovalerylshikonin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 8 |
| Isobutylshikonin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 8 |
| Acetylshikonin | > 128 | > 128 | > 128 | > 128 | > 128 | 8 | 4 |
| Deoxyshikonin | > 128 | > 128 | > 128 | > 128 | > 128 | 8 | 2 |
Table 3 The minimum inhibitory concentrations of psoralen compounds (μg/mL)
| Compound | Klebsiella pneumoniae | Pseudomonas aeruginosa | Acinetobacter baumannii | Staphylococcus aureus | Cryptococcus neoformans | Candida albicans | Helicobacter pylori |
| Isobavachalcone | > 128 | > 128 | > 128 | 8 | 1 | 8 | 8 |
| Bavachin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 8 |
| Bavachinin | > 128 | > 128 | > 128 | 16 | 32 | > 128 | 16 |
| 4'-O-Methylbavachalcone | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 8 |
| Neobavaisoflavone | > 128 | > 128 | > 128 | 64 | 32 | > 128 | 16 |
| Isobavachin | > 128 | > 128 | > 128 | 16 | 32 | > 128 | > 128 |
| Bakuchiol | > 128 | > 128 | > 128 | 32 | 16 | > 128 | > 128 |
| Methoxsalen | > 128 | > 128 | > 128 | 64 | > 128 | > 128 | > 128 |
| Angelicin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| Psoralen | > 128 | > 128 | > 128 | 128 | > 128 | > 128 | > 128 |
| Corylin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| Psoralidin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| Astragalin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
Table 4 The minimum inhibitory concentrations of cinnamon compounds (μg/mL)
| Compound | Staphylococcus aureus | Pseudomonas aeruginosa | Klebsiella pneumoniae | Acinetobacter baumannii | Candida albicans | Cryptococcus neoformans | Helicobacter pylori |
| Cinnamaldehyde | 64 | > 128 | > 128 | > 128 | 128 | 64 | 8 |
| Cinnamic acid | > 128 | > 128 | > 128 | > 128 | > 128 | 128 | 128 |
| Cinnamon alcohol | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 128 |
| Cinnamyl acetate | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| Trans-cinnamic acid | > 128 | > 128 | > 128 | > 128 | 128 | 64 | 128 |
| p-Hydroxy-cinnamic acid | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | 128 |
| 2-Methoxycinnamic acid | > 128 | > 128 | > 128 | > 128 | > 128 | 128 | > 128 |
| Methyl 4-hydroxycinnamate | > 128 | > 128 | > 128 | > 128 | > 128 | 128 | > 128 |
| Ethyl 4-methoxycinnamate | > 128 | > 128 | > 128 | > 128 | > 128 | 128 | 16 |
| 3,4,5-Trimethoxycinnamic acid | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
Table 5 Antibacterial spectrum of betaine (μg/mL)
| Strain | MIC (μg/mL) |
| Bacillus subtilis | 4 |
| Newman | 4 |
| USA300 | 8 |
| Candida albicans | 16 |
| Cryptococcus neoformans | 16 |
| Candida tropicalis | 32 |
| Escherichia coli | > 1024 |
| Staphylococcus haemolyticus | > 1024 |
| Pseudomonas aeruginosa | > 1024 |
| Proteus mirabilis | > 1024 |
| Acinetobacter baumannii | > 1024 |
| Klebsiella pneumoniae | > 1024 |
| Morganella morganii subsp. morganii | > 1024 |
| Enterobacter hormaechei | > 1024 |
Table 6 The minimum inhibitory concentrations of betaine ointment (μg/mL)
| Strain | MIC (μg/mL) | |
| BO | Zicao | |
| Newman | 16 | > 2048 |
| USA300 | 32 | > 2048 |
| Candida albicans | 64 | > 2048 |
| Cryptococcus neoformans | 64 | > 2048 |
| Candida tropicalis | 64 | > 2048 |
| Staphylococcus haemolyticus | > 512 | > 2048 |
| Pseudomonas aeruginosa | > 512 | > 2048 |
| Proteus mirabilis | > 512 | > 2048 |
| Acinetobacter baumannii | > 512 | > 2048 |
| Klebsiella pneumoniae | > 512 | > 2048 |
Table 7 Effect of betaine ointment on scab removal in skin wounds infected with Staphylococcus aureus
Table 8 Effects of betaine ointment on scab removal from skin wounds in diabetic mice infected with Staphylococcus aureus
- Citation: Xu WY, Dai YY, Yang SX, Chen H, Huang YQ, Luo PP, Wei ZH. Betaine combined with traditional Chinese medicine ointment to treat skin wounds in microbially infected diabetic mice. World J Diabetes 2025; 16(1): 99745
- URL: https://www.wjgnet.com/1948-9358/full/v16/i1/99745.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i1.99745
